| abstract |
binding molecules are provided, such as, tcrs or antigen-binding fragments thereof and antibodies and fragments binding to their antigens, such as those that recognize or bind to human papillomavirus (hpv) 16, including hpv16 and6 and hpv16 e7. also provided are modified cells containing such binding molecules, compositions containing the binding molecules or modified cells, and methods of treatment such as administration of the binding molecules, modified cells or compositions. |